Back to Journals » Cancer Management and Research » Volume 10

Whole-body magnetic resonance imaging for the assessment of metastatic breast cancer

Authors Godinho MV, Lopes FP, Costa FM

Received 12 March 2018

Accepted for publication 30 August 2018

Published 6 December 2018 Volume 2018:10 Pages 6743—6756


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Harikrishna Nakshatri

Marcos Vieira Godinho,1,2 Flavia Paiva Proença Lobo Lopes,1,3 Flavia Martins Costa1

1Clinic of Imaging Diagnosis (CDPI), Rio de Janeiro, RJ, Brazil; 2National Institute of Cancer (INCa), Rio de Janeiro, RJ, Brazil; 3Radiology Department, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil

Abstract: Breast cancer is the most common type of tumor in women and an important cause of mortality in the female population. The early and precise diagnosis, staging, and treatment of this neoplasia are essential for public health purposes. Technological development, for example, of whole-body magnetic resonance imaging, made possible the adoption of new imaging modalities for a better approach for these patients. This imaging modality is helpful to staging, to therapy response assessment, and to the study of therapeutic changes in bone marrow, because it gives, at the same time, anatomical information using T1- and T2-weighted images, with high spatial resolution and tissue contrast, as well as functional sequences (diffusion-weighted images), which make possible the detection of hypercellular viable tumors.

Keywords: diffusion, hypercellularity, staging, heterogeneity, chemotherapy, necrosis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]